Sinusitis is one of the most common chronic health problems in the U.S., affecting 37 million Americans each year. Until recently, sinusitis patients were limited to two treatment options: medical therapy such as antibiotics and topical nasal steroids, or conventional sinus surgery.
For 20-25% of sinusitis sufferers, medical therapy alone is not enough. For these patients, sinus surgery is their next hope in finding relief. However, many potential surgery patients have put off surgery because traditional surgeries require bone and tissue removal in order to open blocked sinus passageways.
St. Francis offers an evolution in sinus surgery by using Balloon Sinuplasty technology. When sinus surgery is performed with this new technology, a small, flexible balloon catheter is placed through the nostril into the blocked sinus passageway. Then the balloon is inflated, gently restructuring and opening the sinus passageway, restoring normal sinus drainage and function.
Balloon Sinuplasty enables physicians to treat sinusitis entirely through the nostrils, and in many cases without tissue or bone removal. This may result in reduced bleeding and post-procedure discomfort for patients. In fact, many patients can return to work within 1-2 days.